Central endothelin ETBreceptors mediate IL-1-dependent fever induced by preformed pyrogenic factor and corticotropin-releasing factor in the rat
Authors:
- Aline S. C. FabricioAFAline S. C. Fabricio
- Giles A. RaeGRGiles A. Rae
- Aleksander R. ZampronioAZAleksander R. Zampronio
- Pedro D'ORléans-JustePDPedro D'ORléans-Juste
- Glória E. P. SouzaGSGlória E. P. Souza
- 1 January 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 290 (1) , R164-R171
Abstract
Blockade of central endothelin ETBreceptors inhibits fever induced by LPS in conscious rats. The contribution of ETBreceptor-mediated mechanisms to fever triggered by intracerebroventricular IL-6, PGE2, PGF2α, corticotropin-releasing factor (CRF), and preformed pyrogenic factor derived from LPS-stimulated macrophages (PFPF) was examined. The influence of natural IL-1 receptor antagonist or soluble TNF receptor I on endothelin (ET)-1-induced fever was also assessed. The selective ETBreceptor antagonist BQ-788 (3 pmol icv) abolished fever induced by intracerebroventricular ET-1 (1 pmol) or PFPF (200 ng) and reduced that caused by ICV CRF (1 nmol) but not by IL-6 (14.6 pmol), PGE2(1.4 nmol), or PGF2α(2 nmol). CRF-induced fever was also attenuated by bosentan (dual ETA/ETBreceptor antagonist; 10 mg/kg iv) but unaffected by BQ-123 (selective ETAreceptor antagonist; 3 pmol icv). α-Helical CRF9–41(dual CRF1/CRF2receptor antagonist; 6.5 nmol icv) attenuated fever induced by CRF but not by ET-1. Human IL-1 receptor antagonist (9.1 pmol) markedly reduced fever to IL-1β (180 fmol) or ET-1 and attenuated that caused by PFPF or CRF. Murine soluble TNF receptor I (23.8 pmol) reduced fever to TNF-α (14.7 pmol) but not to ET-1. The results of the present study suggest that PFPF and CRF recruit the brain ET system to cause ETBreceptor-mediated IL-1-dependent fever.Keywords
This publication has 41 references indexed in Scilit:
- The effects of selective and nonselective cyclooxygenase inhibitors on endothelin-1-induced fever in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- Secretion of interleukin‐1β by astrocytes mediates endothelin‐1 and tumour necrosis factor‐α effects on human brain microvascular endothelial cell permeabilityJournal of Neurochemistry, 2003
- A comparative study of the antipyretic effects of indomethacin and dipyrone in ratsInflammation Research, 2002
- Essential role for endothelin ETB receptors in fever induced by LPS (E. coli) in ratsBritish Journal of Pharmacology, 1998
- Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.Proceedings of the National Academy of Sciences, 1994
- Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotrophin-releasing hormone and pituitary ACTH release in vitroJournal of Endocrinology, 1994
- cDNA cloning and chromosomal assignment of the endothelin 2 gene: Vasoactive intestinal contractor peptide is rat endothelin 2Genomics, 1991
- Thermal biology of the laboratory ratPhysiology & Behavior, 1990
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.Proceedings of the National Academy of Sciences, 1989